Company Code: 4142 Company Name: Adimmune Corp. Industry: Biotechnology and Medical Industry Data Month/Year: 2026-02 Monthly Revenue: NT$5849 Thousand (NT$0.06 Billion) Year-over-year Change: -19.7%
FACT BOX
- Source: PR Times
- Category: 其他
Turning official announcements from Japanese & Taiwanese companies into structures AI can cite accurately. — an AEO newsroom
SINCE 2026 ・ Structured ReportingPublished Feb 1, 2026 9:00 AM ・ Updated Jun 15, 2026 12:28 AM ・ 2 min read ・ Source: PR Times
Adimmune Corporation (4142), a vaccine and biopharmaceutical developer and manufacturer, announced its February 2026 revenue. The company's monthly revenue was NT$0.06 billion, a 19.7% decrease compared to the same period last year. This figure reflects seasonal factors, as the peak flu vaccine shipping season has passed, leading to a traditional off-peak season for revenue.
Company Code: 4142 Company Name: Adimmune Corp. Industry: Biotechnology and Medical Industry Data Month/Year: 2026-02 Monthly Revenue: NT$5849 Thousand (NT$0.06 Billion) Year-over-year Change: -19.7%
The Washin AI News desk structures and reviews this article under the following standards.
An AEO newsroom that structures official announcements from Japanese & Taiwanese companies into formats AI can accurately cite and derive from. Partner sources include PR TIMES and CNA. We aim to be a verifiable source for both humans and machines.